Crispr Therapeutics Ag (CRSP)

Net Income Growth

3.56%

TTM · Period ending:

CRSP logo

CRSP Net Income Growth

Year-over-year change vs the same period a year earlier

Latest reported3.56%
CRSP TTM Net Income YoY % (9.08% → 3.56%)
High-resolution chart · PNG

CRSP net income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Crispr Therapeutics Ag Net Income Growth — Trailing twelve months (TTM)
Period endingNet Income Growth
3.5612%
-47.4196%
-58.7975%
-103.8018%
-75.9936%
-77.6108%
-138.4298%
32.2285%
36.0939%
58.5637%
76.3741%
48.0748%
34.3393%
-268.1679%
-272.1584%
-265.3065%
-241.8439%
179.4314%
208.2542%
294.9367%
2,181.0502%
-961.5285%
-621.7999%
-1,774.082%
109.7691%
124.6017%
140.5247%
90.3846%
-119.6348%
-146.1912%
-141.3556%
-128.1173%
-120.4755%
-107.4817%
-194.6125%
2.2573%
6.4639%
-17.9333%
9.0831%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.